PrescriptionDrugs.org

What to Expect When Starting Naltrexone

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Naltrexone (ReVia, Vivitrol) is an opioid receptor antagonist used to support treatment of alcohol use disorder (AUD) and opioid use disorder (OUD). For OUD, the patient must be completely opioid-free for at least 7-10 days before starting to avoid precipitated withdrawal. For AUD, no opioid washout is needed. Naltrexone reduces the rewarding effects of alcohol and opioids and helps reduce cravings.

Week-by-week timeline

Before Starting

Opioid-Free Period (for OUD)

If starting for opioid use disorder, you must be completely opioid-free for at least 7-10 days (14 days for methadone). A naloxone challenge test may be performed to confirm opioid-free status before the first dose.

Week 1

Initiating Treatment

For oral naltrexone, treatment starts at 25-50 mg daily. Common early side effects include nausea, headache, anxiety, and fatigue. Nausea is most common in the first 1-2 weeks and improves. Take with food to reduce nausea.

Weeks 2-4

Craving Reduction

Cravings for alcohol or opioids typically begin to reduce. For alcohol use disorder, some patients use the Sinclair Method (taking naltrexone before drinking). Naltrexone does not make you sick from alcohol — it reduces the pleasure and reinforcement.

Weeks 4-8

Building Behavioral Change

Naltrexone works best alongside counseling and behavioral therapies. Medication compliance is critical — the oral form requires daily adherence. The monthly injection (Vivitrol) eliminates the need for daily dosing.

Month 3+

Sustained Recovery Support

Naltrexone is effective for at least 6-12 months as part of a comprehensive treatment plan. Regular monitoring of liver function is recommended. Long-term use is safe for most patients.

When to call your doctor

Contact your healthcare provider if you experience:

  • If you use opioids while on naltrexone: tell emergency responders you are on naltrexone as it can block pain relief medications
  • Signs of liver problems: yellowing of skin or eyes, dark urine, severe stomach pain
  • Severe depression or thoughts of self-harm
  • Severe allergic reaction: difficulty breathing, facial swelling
  • Injection site reactions with Vivitrol: severe pain, hardness, or tissue damage
  • Severe nausea or vomiting lasting more than a few days

Tips for getting started

If starting for opioid use disorder, confirm with your doctor that you have been completely opioid-free long enough — starting too early causes sudden, severe withdrawal. For alcohol use disorder, naltrexone does not require abstinence before starting. Consider the monthly injection (Vivitrol) if daily pill adherence is a challenge. Combine with counseling or support groups (AA, SMART Recovery) for the best outcomes. Carry a medical ID card noting naltrexone use for emergency situations.

Frequently asked questions

More about Naltrexone

References

  1. [Regulatory] FDA Prescribing Information for ReVia (naltrexone) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018932s017lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] SAMHSA Treatment of Opioid Use Disorder https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/naltrexone Accessed 2026-03-01.
  3. [Regulatory] NIAAA: Naltrexone for Alcohol Use Disorder https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-use-disorder/treatment Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: